Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
Sicheng Yan,Yuxuan He,Yuehong Zhu,Wangfang Ye,Yan Chen,Cong Zhu,Fuyuan Zhan,Zhihong Ma
DOI: https://doi.org/10.3389/fcell.2024.1384450
IF: 5.5
2024-04-05
Frontiers in Cell and Developmental Biology
Abstract:Gastrointestinal cancers account for approximately one-third of the total global cancer incidence and mortality with a poor prognosis. It is one of the leading causes of cancer-related deaths worldwide. Most of these diseases lack effective treatment, occurring as a result of inappropriate models to develop safe and potent therapies. As a novel preclinical model, tumor patient-derived organoids (PDOs), can be established from patients' tumor tissue and cultured in the laboratory in 3D architectures. This 3D model can not only highly simulate and preserve key biological characteristics of the source tumor tissue in vitro but also reproduce the in vivo tumor microenvironment through co-culture. Our review provided an overview of the different in vitro models in current tumor research, the derivation of cells in PDO models, and the application of PDO model technology in gastrointestinal cancers, particularly the applications in combination with CRISPR/Cas9 gene editing technology, tumor microenvironment simulation, drug screening, drug development, and personalized medicine. It also elucidates the ethical status quo of organoid research and the current challenges encountered in clinical research, and offers a forward-looking assessment of the potential paths for clinical organoid research advancement.
cell biology,developmental biology